$Olema Pharmaceuticals (OLMA.US)$ From past trends, December tends to be when the stock price takes a dive as investors are looking at other more dynamic stocks to invest in. Feb and Jul seems to be when the stock price tends to get an uplift. The drop off is especially drastic this Dec given the significant interest in all things crypto, Trump and AI related after the recent election. There's been generally good news from Olem...
$Olema Pharmaceuticals (OLMA.US)$ Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination with Ribociclib at the San Antonio Breast Cancer Symposium Olema Oncology announced updated clinical results for palazestrant combined with ribociclib in treating ER+/HER2- advanced or metastatic breast cancer. With a 12-month median follow-up, the study showed promising results with median progression-free survival (PFS) not yet reached. The 6-month PFS rate was 73% overall, wit...
1
Report
104079172
:
I attended the pre-symposium analyst presentation of just now and the results of the current 6 month in phase trial for Olema's palazestrant is extremely promising pre the big upcoming trial in 2025
$Olema Pharmaceuticals (OLMA.US)$Reuters· 1 min ago Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination With Ribociclib at the San Antonio Breast Cancer Symposium
4
Report
104079172
:
The analyst presentation today of the same data that will be presented at the symposium was extremely good. Good chance the stock price will go up well in the next few days
104079172
:
Yes indeed. I suspect that most retail investors have their attention elsewhere. And the institutions are in it for the long haul hence the volume is really bad. This company will do well in 12 months. High chance that Novartis might acquire it given that it doesn't currently have a similar promising drug in its own pipeline (it's own type has no news for a long time and Olema seems to be clever enough to partner with Novartis to do a ribo combo with Palazestrant in its ongoing phase trials)
$Olema Pharmaceuticals (OLMA.US)$ Olema Oncology Announces FDA Clearance of Investigational New Drug Application for OP-3136, a Potent KAT6 Inhibitor Olema Pharmaceuticals (Nasdaq: OLMA) announced FDA clearance of its Investigational New Drug (IND) application for OP-3136, a novel small molecule that inhibits KAT6, an epigenetic target involved in breast and other cancers. The company plans to initiate a Phase 1 clinical trial in early 2025. OP-3136 has shown promising preclinical activity ...
$Olema Pharmaceuticals (OLMA.US)$Olema Oncology Announces FDA Clearance of Investigational New Drug Application for OP-3136, a Potent KAT6 Inhibitor 4 MINUTES AGO, 7:00 AM EST VIA GLOBENEWSWIRE
$Olema Pharmaceuticals (OLMA.US)$Reuters· 3 mins ago Olema Oncology Announces New Clinical Trial Collaboration and Supply Agreement With Novartis in Frontline Metastatic Breast Cancer as Well as $250 Million Equity Private Placement
$Olema Pharmaceuticals (OLMA.US)$Olema Oncology to Present New Data Combining Palazestrant With Ribociclib at the San Antonio Breast Cancer Symposium Olema will host an investor conference call at 8:00 a.m. ET on December 10, 2024 Poster Details Title:A Phase 1b/2 study of palazestrant (OP-1250) in combination with ribociclib, in patients with estrogen receptor-positive, human epidermal gr...
Trytosaveabit
OPjoeyboulevard
:
Test? Sorry when it comes to me giving any type of answer. The question needs to be much more clear/direct! Hehehe! To many ways my simple mind can go with this. Hehehe. Hope you’re having a good weekend!
Trytosaveabit
OPMARKET-TEST-DUMMY
:
Good stuff! Hehehe. Hope you’re having a great weekend. BTW with the wind today so far it feels like it’s about 19’ Hehehe. And I bet you’re working outside in a T! Hehehe
Although the sale doesn't necessarily signify a negative view on the company's future, absence of insider buying could induce concerns. Other company risks should be considered when investing.
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
Olema Pharmaceuticals Stock Forum
Cancer Breakthrough: New Drug Shows Powerful Anti-Tumor Effects in Prostate, Ovarian, Lung Cancers
From past trends, December tends to be when the stock price takes a dive as investors are looking at other more dynamic stocks to invest in. Feb and Jul seems to be when the stock price tends to get an uplift. The drop off is especially drastic this Dec given the significant interest in all things crypto, Trump and AI related after the recent election.
There's been generally good news from Olem...
Olema set for an operatic debut at last | ApexOnco - Clinical Trials news and analysis
Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination with Ribociclib at the San Antonio Breast Cancer Symposium
Olema Oncology announced updated clinical results for palazestrant combined with ribociclib in treating ER+/HER2- advanced or metastatic breast cancer. With a 12-month median follow-up, the study showed promising results with median progression-free survival (PFS) not yet reached. The 6-month PFS rate was 73% overall, wit...
Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination With Ribociclib at the San Antonio Breast Cancer Symposium
Olema Oncology Announces FDA Clearance of Investigational New Drug Application for OP-3136, a Potent KAT6 Inhibitor
Olema Pharmaceuticals (Nasdaq: OLMA) announced FDA clearance of its Investigational New Drug (IND) application for OP-3136, a novel small molecule that inhibits KAT6, an epigenetic target involved in breast and other cancers. The company plans to initiate a Phase 1 clinical trial in early 2025. OP-3136 has shown promising preclinical activity ...
4 MINUTES AGO, 7:00 AM EST
VIA GLOBENEWSWIRE
Olema Oncology Announces New Clinical Trial Collaboration and Supply Agreement With Novartis in Frontline Metastatic Breast Cancer as Well as $250 Million Equity Private Placement
Olema will host an investor conference call at 8:00 a.m. ET on December 10, 2024
Poster Details
Title:A Phase 1b/2 study of palazestrant (OP-1250) in combination with ribociclib, in patients with estrogen receptor-positive, human epidermal gr...
No comment yet